These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 30841948)
21. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study. Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292 [TBL] [Abstract][Full Text] [Related]
22. Association of Clostridium difficile infections with acid suppression medications in children. Nylund CM; Eide M; Gorman GH J Pediatr; 2014 Nov; 165(5):979-84.e1. PubMed ID: 25112692 [TBL] [Abstract][Full Text] [Related]
23. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study. Park YH; Seong JM; Cho S; Han HW; Kim JY; An SH; Gwak HS J Gastroenterol; 2019 Dec; 54(12):1052-1060. PubMed ID: 31187275 [TBL] [Abstract][Full Text] [Related]
24. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. Cao F; Chen CX; Wang M; Liao HR; Wang MX; Hua SZ; Huang B; Xiong Y; Zhang JY; Xu YL J Hosp Infect; 2018 Jan; 98(1):4-13. PubMed ID: 28842261 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology and risk factors for Clostridium difficile infection in children. Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782 [TBL] [Abstract][Full Text] [Related]
31. Regional differences in Clostridium difficile infections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008-2011. Kanerva M; Ollgren J; Voipio T; Mentula S; Lyytikäinen O Infect Dis (Lond); 2015 Aug; 47(8):530-5. PubMed ID: 25832317 [TBL] [Abstract][Full Text] [Related]
32. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children. Ochfeld E; Balmert LC; Patel SJ; Muller WJ; Kociolek LK Transpl Infect Dis; 2019 Oct; 21(5):e13149. PubMed ID: 31332916 [TBL] [Abstract][Full Text] [Related]
33. Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis. Tariq R; Cho J; Kapoor S; Orenstein R; Singh S; Pardi DS; Khanna S Clin Infect Dis; 2018 Feb; 66(4):514-522. PubMed ID: 29401273 [TBL] [Abstract][Full Text] [Related]
34. Acid suppression and the risk of Clostridium difficile infection. Mezoff EA; Cohen MB J Pediatr; 2013 Sep; 163(3):627-30. PubMed ID: 23759424 [No Abstract] [Full Text] [Related]
35. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset. Kimura T; Snijder R; Sugitani T J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950 [TBL] [Abstract][Full Text] [Related]
36. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review. Ciricillo J; Haslam D; Blum S; Kim MO; Liu C; Paulsen G; Courter J; Danziger-Isakov L Transpl Infect Dis; 2016 Oct; 18(5):706-713. PubMed ID: 27492796 [TBL] [Abstract][Full Text] [Related]
37. Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance. Tschudin-Sutter S; Tamma PD; Naegeli AN; Speck KA; Milstone AM; Perl TM Clin Infect Dis; 2013 Dec; 57(12):1665-72. PubMed ID: 24046303 [TBL] [Abstract][Full Text] [Related]
38. The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence. Moreels N; Boven A; Gressani O; Andersson FL; Vlieghe E; Callens S; Engstrand L; Simin J; Brusselaers N J Antimicrob Chemother; 2024 Mar; 79(3):608-616. PubMed ID: 38267263 [TBL] [Abstract][Full Text] [Related]